CARM1 promotes non-small cell lung cancer progression through upregulating CCNE2 expression
Open Access
- 2 June 2020
- journal article
- research article
- Published by Impact Journals, LLC in Aging
- Vol. 12 (11), 10578-10593
- https://doi.org/10.18632/aging.103280
Abstract
The underlying molecular mechanisms of tumorigenesis and progression of non-small cell lung cancer (NSCLC) are not yet fully elucidated. In the present study, in vitro functional dissections suggest that siRNA-mediated silencing of CCNE2 profoundly attenuated the proliferative and colony-formative abilities of NSCLC PC9 and HCC827 cells, while forced overexpression of CCNE2 significantly strengthened the proliferative and colony-formative capabilities of these cells. Intriguingly, by ChIP and luciferase reporter gene assays, we observed that CARM1 is recruited to the promoter regions of CCNE2 gene and acts as a transcriptional activator. Mechanically, the asymmetric di-methylation of H3R17me2a and H3R26me2a, as the catalytic substrates of CARM1, were highly enriched at the core promoter regions of CCNE2 gene, thereby activating the expression of CCNE2. In vitro and in vivo rescue experiments demonstrated that restoration of CCNE2 expression significantly abolished the CARM1 shRNA-mediated inhibition of cell proliferation, indicating that the oncogenic function of CARM1, at least partially, depended on the activation of CCNE2. Inhibition of CARM1 enzymatic activity could significantly repress CCNE2 expression in NSCLC cells. In addition, the expression of CARM1 was significantly elevated and positively correlated with CCNE2 levels in 20 cases of NSCLC patients. Both CARM1 and CCNE2 are highly associated with shorter 10-year overall survival of at a large cohort of 461 cases of NSCLC patients from the Kaplan-Meier plotter database. To summarize, these findings provide compelling evidence that CARM1 could promote NSCLC progression via activation of CCNE2, paving the way for future therapeutic strategies in NSCLC.Keywords
This publication has 32 references indexed in Scilit:
- Protein arginine methyltransferases and cancerNature Reviews Cancer, 2012
- Molecular Pathology of Non–Small Cell Lung CancerAmerican Journal of Clinical Pathology, 2012
- CARM1 Is an Important Determinant of ERα-Dependent Breast Cancer Cell Differentiation and Proliferation in Breast Cancer CellsCancer Research, 2011
- Regulated recruitment of tumor suppressor BRCA1 to the p21 gene by coactivator methylationGenes & Development, 2011
- CARM1 is required for proper control of proliferation and differentiation of pulmonary epithelial cellsDevelopment, 2010
- Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and SurvivorshipMayo Clinic Proceedings, 2008
- Coactivator-associated arginine methyltransferase 1 (CARM1) is a positive regulator of the Cyclin E1 geneProceedings of the National Academy of Sciences of the United States of America, 2006
- Cyclin EThe International Journal of Biochemistry & Cell Biology, 2004
- Regulation of Transcription by a Protein MethyltransferaseScience, 1999